Search

Your search keyword '"Deckert, Martina"' showing total 1,115 results

Search Constraints

Start Over You searched for: Author "Deckert, Martina" Remove constraint Author: "Deckert, Martina"
1,115 results on '"Deckert, Martina"'

Search Results

201. Liver Cell Carcinoma

202. Lack of ADH or ADH Action

203. Lung Disease in Hay Fever

204. Lafora’s Progressive Myoclonus Epilepsy

205. Lung Disease in EBV Infection

206. Lichen Ruber Planus

207. Lentigines, Atrial Myxomas and Blue Nevi

208. Large Vessel Vasculitis

209. Late-Onset Multiple Carboxylase Deficiency

210. Left Ventricular Hypertrabeculation

211. Left Ventricular Fibrosis

212. Late-Onset Prurigo of Pregnancy

213. Lecithin Cholesterol Acyltransferase Deficiency

214. Leiomyomatosis and Renal Cell Cancer, Hereditary

215. Leg Jerks

216. Lewy Body Dementia

220. Analysis of Driver Mutational Hot Spots in Blood-Derived Cell-Free DNA of Patients with Primary Central Nervous System Lymphoma Obtained before Intracerebral Biopsy

221. Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphoma

222. A Multiplex Assay for the Stratification of Patients with Primary Central Nervous System Lymphoma Using Targeted Mass Spectrometry

223. CXCR4-Targeted PET Imaging of Central Nervous System B-Cell Lymphoma

224. KLF4K409Q–mutated meningiomas show enhanced hypoxia signaling and respond to mTORC1 inhibitor treatment

225. The deubiquitinase OTUB1 augments NF-κB-dependent immune responses in dendritic cells in infection and inflammation by stabilizing UBC13

231. Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF

232. CXCR4-Targeted Positron Emission Tomography Imaging of Central Nervous System B-Cell Lymphoma

233. A tissue‐specific screen of ceramide expression in aged mice identifies ceramide synthase‐1 and ceramide synthase‐5 as potential regulators of fiber size and strength in skeletal muscle

234. CBMT-25. THE KLF4K409Q MUTATION IN MENINGIOMA IMPAIRS HIF-1Α DEGRADATION AND CAN BE HARNESSED FOR TARGETED THERAPY

239. Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: Results of a phase II study

242. Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)

243. High-Dose Chemotherapy and Autologous Stem Cell Transplant in Elderly and Fit Primary CNS Lymphoma Patients - a Multicenter Study By the Cooperative PCNSL Study Group (MARTA study)

246. Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial

247. Additional file 4: of Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities

248. Additional file 2: of Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities

249. Additional file 5: of Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities

250. MOESM2 of Bi-allelic mutations in uncoordinated mutant number-45 myosin chaperone B are a cause for congenital myopathy

Catalog

Books, media, physical & digital resources